JPH05221980A - アセチレン化合物 - Google Patents

アセチレン化合物

Info

Publication number
JPH05221980A
JPH05221980A JP4286027A JP28602792A JPH05221980A JP H05221980 A JPH05221980 A JP H05221980A JP 4286027 A JP4286027 A JP 4286027A JP 28602792 A JP28602792 A JP 28602792A JP H05221980 A JPH05221980 A JP H05221980A
Authority
JP
Japan
Prior art keywords
methyl
formula
compound
salt
benzenesulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4286027A
Other languages
English (en)
Japanese (ja)
Inventor
Marc Gerspacher
ゲルスパッヒャー マルク
Alfred Sallmann
サルマン アルフレット
Rolf Schurter
シュルター ロルフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPH05221980A publication Critical patent/JPH05221980A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
JP4286027A 1991-10-25 1992-10-23 アセチレン化合物 Pending JPH05221980A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH03135/91-8 1991-10-25
CH313591 1991-10-25

Publications (1)

Publication Number Publication Date
JPH05221980A true JPH05221980A (ja) 1993-08-31

Family

ID=4249377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4286027A Pending JPH05221980A (ja) 1991-10-25 1992-10-23 アセチレン化合物

Country Status (13)

Country Link
US (1) US5248693A (enExample)
EP (1) EP0539329A1 (enExample)
JP (1) JPH05221980A (enExample)
KR (1) KR930007902A (enExample)
AU (1) AU2723292A (enExample)
CA (1) CA2081262A1 (enExample)
FI (1) FI924768L (enExample)
HU (1) HUT65627A (enExample)
IL (1) IL103524A0 (enExample)
MX (1) MX9206127A (enExample)
NO (1) NO924112L (enExample)
TW (1) TW207531B (enExample)
ZA (1) ZA928201B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021512172A (ja) * 2018-01-23 2021-05-13 セインダ ファーマシューティカル グアンジョウ コーポレイション 眼科的薬学的組成物、その調製方法、およびその適用

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072125T3 (es) * 1991-10-25 1995-07-01 Ciba Geigy Ag Procedimiento para la obtencion de indoles substituidos.
US5439929A (en) * 1994-03-01 1995-08-08 Pfizer Inc. Bicyclic carbamates, pharmaceutical compositions and use
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) * 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
ES2273725T3 (es) 1999-09-04 2007-05-16 Astrazeneca Ab Derivados de hidroxiacetamidobencenosulfonamida.
ES2307528T3 (es) 1999-09-04 2008-12-01 Astrazeneca Ab Amidas como inhibidores para la piruvato deshidrogenasa.
ES2216940T3 (es) 1999-09-04 2004-11-01 Astrazeneca Ab Derivados n-fenilicos de 2-hidroxi-2-metil-3,3,3-trifluoropropanamida sustituidos que elevan la actividad de piruvato deshidrogenasa.
GB0120471D0 (en) * 2001-08-23 2001-10-17 Astrazeneca Ab Chemical compounds
EP2981324B1 (en) * 2013-04-05 2020-01-01 Miller, Leonard B. Methods and articles of manufacture for the treatment of skin
CN108084077B (zh) * 2017-12-20 2020-04-14 江汉大学 一种扎鲁司特中间体的合成方法
CN115458713B (zh) * 2022-10-21 2024-04-19 深圳市山木新能源科技股份有限公司 一种聚阴离子钠离子电池电极

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
DK496086A (da) * 1985-10-17 1987-04-18 Ici America Inc Heterocykliske forbindelser
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
DE59103389D1 (de) * 1990-05-04 1994-12-08 Ciba Geigy Ag Substituierte Indole.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021512172A (ja) * 2018-01-23 2021-05-13 セインダ ファーマシューティカル グアンジョウ コーポレイション 眼科的薬学的組成物、その調製方法、およびその適用

Also Published As

Publication number Publication date
TW207531B (enExample) 1993-06-11
US5248693A (en) 1993-09-28
FI924768A0 (fi) 1992-10-21
HU9203343D0 (en) 1992-12-28
IL103524A0 (en) 1993-03-15
KR930007902A (ko) 1993-05-20
FI924768A7 (fi) 1993-04-26
AU2723292A (en) 1993-04-29
NO924112L (no) 1993-04-26
CA2081262A1 (en) 1993-04-26
EP0539329A1 (de) 1993-04-28
MX9206127A (es) 1993-08-01
FI924768L (fi) 1993-04-26
HUT65627A (en) 1994-07-28
ZA928201B (en) 1993-04-28
NO924112D0 (no) 1992-10-23

Similar Documents

Publication Publication Date Title
LT3182B (en) Novel substituted salicylic acids
JPS6391381A (ja) ジヒドロベンゾピラン誘導体
JPH05221980A (ja) アセチレン化合物
JPS62155250A (ja) フエノキシアルキルカルボン酸およびエステル化合物，その製造方法および該化合物を含有する医薬組成物
JPS58194887A (ja) １，８−ナフチリジンおよび１，５，８−アザナフチリジン誘導体類
SU831074A3 (ru) Способ получени производных бензимида-зОлА
KR100281867B1 (ko) 3-(비스-치환페닐메틸렌)옥신돌유도체
JPH0536436B2 (enExample)
US5096917A (en) Substituted indoles
IE55377B1 (en) 1,5-diphenylpyrazolin-3-one compounds,method for preparing them,and pharmaceutical compositions containing these compounds
JP3117466B2 (ja) ベンゼン誘導体
US5508408A (en) Quinoline compound
JPS6222992B2 (enExample)
JP2001507711A (ja) テトラゾリルベンゾピランの製法
JPH05500060A (ja) 置換キノリン類
JPS6352621B2 (enExample)
JPH10273464A (ja) 置換カテコール誘導体
JPH02250831A (ja) ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びそれを有効成分とする抗消化性潰瘍剤
JPH0454666B2 (enExample)
KR890004662B1 (ko) 1,8-나프티리딘과 1,5,8-아자나프티리딘 유도체 및 이의 제조방법
FR2581996A1 (fr) Nouveaux derives 6-substitues de 6h-dibenzo(b, d)thiopyranne utiles notamment immunomodulateurs et antiviraux et leur preparation
JPH09124608A (ja) シクロプロパン誘導体及びそれを含有する抗ウイルス剤
JPH05339234A (ja) ヘキサヒドロインデノ〔１，２−ｂ〕ピロール誘導体
JPH06107546A (ja) Ａｄｍ耐性解除剤
JPH05201975A (ja) 置換インドールの製造方法